162 related articles for article (PubMed ID: 16820142)
1. Thrombospondin-1 antagonizes nitric oxide-stimulated vascular smooth muscle cell responses.
Isenberg JS; Wink DA; Roberts DD
Cardiovasc Res; 2006 Sep; 71(4):785-93. PubMed ID: 16820142
[TBL] [Abstract][Full Text] [Related]
2. CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1.
Isenberg JS; Ridnour LA; Dimitry J; Frazier WA; Wink DA; Roberts DD
J Biol Chem; 2006 Sep; 281(36):26069-80. PubMed ID: 16835222
[TBL] [Abstract][Full Text] [Related]
3. Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner.
Isenberg JS; Ridnour LA; Perruccio EM; Espey MG; Wink DA; Roberts DD
Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13141-6. PubMed ID: 16150726
[TBL] [Abstract][Full Text] [Related]
4. Thrombospondin-1 inhibition of vascular smooth muscle cell responses occurs via modulation of both cAMP and cGMP.
Yao M; Roberts DD; Isenberg JS
Pharmacol Res; 2011 Jan; 63(1):13-22. PubMed ID: 20971192
[TBL] [Abstract][Full Text] [Related]
5. Thrombospondin-1 inhibits nitric oxide signaling via CD36 by inhibiting myristic acid uptake.
Isenberg JS; Jia Y; Fukuyama J; Switzer CH; Wink DA; Roberts DD
J Biol Chem; 2007 May; 282(21):15404-15. PubMed ID: 17416590
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of ABT-510 and a CD36-binding peptide derived from the type 1 repeats of thrombospondin-1 on fatty acid uptake, nitric oxide signaling, and caspase activation in vascular cells.
Isenberg JS; Yu C; Roberts DD
Biochem Pharmacol; 2008 Feb; 75(4):875-82. PubMed ID: 18068687
[TBL] [Abstract][Full Text] [Related]
7. Statins and nitric oxide donors affect thrombospondin 1-induced chemotaxis.
Seymour K; Stein J; Han X; Maier KG; Gahtan V
Vasc Endovascular Surg; 2014; 48(7-8):470-5. PubMed ID: 25361959
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of nitric oxide on thrombospondin-1-, PDGF- and fibronectin-induced migration of vascular smooth muscle cells.
Seymour K; Han X; Sadowitz B; Maier KG; Gahtan V
Am J Surg; 2010 Nov; 200(5):615-9. PubMed ID: 21056139
[TBL] [Abstract][Full Text] [Related]
9. Role of redox signaling and poly (adenosine diphosphate-ribose) polymerase activation in vascular smooth muscle cell growth inhibition by nitric oxide and peroxynitrite.
Huang J; Lin SC; Nadershahi A; Watts SW; Sarkar R
J Vasc Surg; 2008 Mar; 47(3):599-607. PubMed ID: 18295111
[TBL] [Abstract][Full Text] [Related]
10. Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling.
Isenberg JS; Romeo MJ; Yu C; Yu CK; Nghiem K; Monsale J; Rick ME; Wink DA; Frazier WA; Roberts DD
Blood; 2008 Jan; 111(2):613-23. PubMed ID: 17890448
[TBL] [Abstract][Full Text] [Related]
11. Dyslipidemia regulates thrombospondin-1-induced vascular smooth muscle cell chemotaxis.
Desai P; Stein JJ; Siddiqui SA; Maier KG; Gahtan V
Mol Cell Biochem; 2015 Dec; 410(1-2):85-91. PubMed ID: 26350564
[TBL] [Abstract][Full Text] [Related]
12. Adipokines enhance oleic acid-induced proliferation of vascular smooth muscle cells by inducing CD36 expression.
Schlich R; Lamers D; Eckel J; Sell H
Arch Physiol Biochem; 2015; 121(3):81-7. PubMed ID: 26135380
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide activates PI3-K and MAPK signalling pathways in human and rat vascular smooth muscle cells: influence of insulin resistance and oxidative stress.
Doronzo G; Viretto M; Russo I; Mattiello L; Di Martino L; Cavalot F; Anfossi G; Trovati M
Atherosclerosis; 2011 May; 216(1):44-53. PubMed ID: 21316056
[TBL] [Abstract][Full Text] [Related]
14. Differential interactions of thrombospondin-1, -2, and -4 with CD47 and effects on cGMP signaling and ischemic injury responses.
Isenberg JS; Annis DS; Pendrak ML; Ptaszynska M; Frazier WA; Mosher DF; Roberts DD
J Biol Chem; 2009 Jan; 284(2):1116-25. PubMed ID: 19004835
[TBL] [Abstract][Full Text] [Related]
15. Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide-mediated vascular smooth muscle relaxation.
Isenberg JS; Hyodo F; Matsumoto K; Romeo MJ; Abu-Asab M; Tsokos M; Kuppusamy P; Wink DA; Krishna MC; Roberts DD
Blood; 2007 Mar; 109(5):1945-52. PubMed ID: 17082319
[TBL] [Abstract][Full Text] [Related]
16. Endogenous thrombospondin-1 is not necessary for proliferation but is permissive for vascular smooth muscle cell responses to platelet-derived growth factor.
Isenberg JS; Calzada MJ; Zhou L; Guo N; Lawler J; Wang XQ; Frazier WA; Roberts DD
Matrix Biol; 2005 Apr; 24(2):110-23. PubMed ID: 15890262
[TBL] [Abstract][Full Text] [Related]
17. TLR 2 induces vascular smooth muscle cell migration through cAMP response element-binding protein-mediated interleukin-6 production.
Lee GL; Chang YW; Wu JY; Wu ML; Wu KK; Yet SF; Kuo CC
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2751-60. PubMed ID: 22995520
[TBL] [Abstract][Full Text] [Related]
18. Thrombospondin-1 differentially induces chemotaxis and DNA synthesis of human venous smooth muscle cells at the receptor-binding level.
Lymn JS; Patel MK; Clunn GF; Rao SJ; Gallagher KL; Hughes AD
J Cell Sci; 2002 Nov; 115(Pt 22):4353-60. PubMed ID: 12376566
[TBL] [Abstract][Full Text] [Related]
19. Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells.
Aizawa T; Wei H; Miano JM; Abe J; Berk BC; Yan C
Circ Res; 2003 Sep; 93(5):406-13. PubMed ID: 12919948
[TBL] [Abstract][Full Text] [Related]
20. oxLDL induces inflammatory responses in vascular smooth muscle cells via urokinase receptor association with CD36 and TLR4.
Kiyan Y; Tkachuk S; Hilfiker-Kleiner D; Haller H; Fuhrman B; Dumler I
J Mol Cell Cardiol; 2014 Jan; 66():72-82. PubMed ID: 24239845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
